 | • レポートコード：QYR9ST01883 • 出版社/出版日：QYResearch / 2019年9月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、113ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医薬品・医療 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※本調査レポートでは、世界の抗炎症治療薬市場について調査・分析し、以下の構成でお届け致します。抗炎症治療薬の種類別には、抗炎症生物、NSAID、コルチコステロイドに、用途別には、病院、診療所に、地域別には、北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカなどに区分してセグメント分析を行いました。 ・調査販売 ・エグゼクティブ・サマリー ・企業別抗炎症治療薬売上データ ・地域別抗炎症治療薬市場規模：北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカ、その他 ・種類別抗炎症治療薬市場規模：抗炎症生物、NSAID、コルチコステロイド ・用途別抗炎症治療薬市場規模：病院、診療所 ・主要メーカーの企業情報：AbbVie、Amgen、Johnson & Johnson、Pfizer、Boehringer Ingelheim、Eli Lilly、Novartis ・抗炎症治療薬の市場規模予測 ・バリューチェーン及び販売チャネル分析 ・市場機会・課題・リスク・影響因子分析 ... |
Anti-inflammatory therapeutics are primarily used to reduce inflammation. These drugs are types of analgesics that are used for reducing pain.The global anti-inflammatory therapeutics market will grow steadily at a CAGR of over 6% by 2021. This market research analysis identifies the increase in the prevalence of immune-mediated inflammatory disease (IMID) as one of the primary growth factors for this market. IMID includes a group of disabling conditions that share a common inflammatory pathway including conditions like ankylosing spondylitis (AS), ulcerative colitis, multiple sclerosis (MS), rheumatoid arthritis (RA), and inflammatory bowel disease (IBD) and these conditions can affect an organ, resulting in significant morbidity and reduced quality of life.
The global Anti-inflammatory Therapeutics market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Anti-inflammatory Therapeutics market based on company, product type, end user and key regions.
This report studies the global market size of Anti-inflammatory Therapeutics in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Anti-inflammatory Therapeutics in these regions.
This research report categorizes the global Anti-inflammatory Therapeutics market by top players/brands, region, type and end user. This report also studies the global Anti-inflammatory Therapeutics market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
AbbVie
Amgen
Johnson & Johnson
Pfizer
Boehringer Ingelheim
Eli Lilly
Novartis
Market size by Product
Anti-Inflammatory Biologicals
NSAIDs
Corticosteroids
Market size by End User
Hospitals
Clinics
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Anti-inflammatory Therapeutics market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Anti-inflammatory Therapeutics market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Anti-inflammatory Therapeutics companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Anti-inflammatory Therapeutics submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Anti-inflammatory Therapeutics are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Anti-inflammatory Therapeutics market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
レポート目次Table of Contents
1 Study Coverage
1.1 Anti-inflammatory Therapeutics Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Anti-inflammatory Therapeutics Market Size Growth Rate by Product
1.4.2 Anti-Inflammatory Biologicals
1.4.3 NSAIDs
1.4.4 Corticosteroids
1.5 Market by End User
1.5.1 Global Anti-inflammatory Therapeutics Market Size Growth Rate by End User
1.5.2 Hospitals
1.5.3 Clinics
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Anti-inflammatory Therapeutics Market Size
2.1.1 Global Anti-inflammatory Therapeutics Revenue 2014-2025
2.1.2 Global Anti-inflammatory Therapeutics Sales 2014-2025
2.2 Anti-inflammatory Therapeutics Growth Rate by Regions
2.2.1 Global Anti-inflammatory Therapeutics Sales by Regions
2.2.2 Global Anti-inflammatory Therapeutics Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 Anti-inflammatory Therapeutics Sales by Manufacturers
3.1.1 Anti-inflammatory Therapeutics Sales by Manufacturers
3.1.2 Anti-inflammatory Therapeutics Sales Market Share by Manufacturers
3.1.3 Global Anti-inflammatory Therapeutics Market Concentration Ratio (CR5 and HHI)
3.2 Anti-inflammatory Therapeutics Revenue by Manufacturers
3.2.1 Anti-inflammatory Therapeutics Revenue by Manufacturers (2014-2019)
3.2.2 Anti-inflammatory Therapeutics Revenue Share by Manufacturers (2014-2019)
3.3 Anti-inflammatory Therapeutics Price by Manufacturers
3.4 Anti-inflammatory Therapeutics Manufacturing Base Distribution, Product Types
3.4.1 Anti-inflammatory Therapeutics Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Anti-inflammatory Therapeutics Product Type
3.4.3 Date of International Manufacturers Enter into Anti-inflammatory Therapeutics Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
4.1 Global Anti-inflammatory Therapeutics Sales by Product
4.2 Global Anti-inflammatory Therapeutics Revenue by Product
4.3 Anti-inflammatory Therapeutics Price by Product
5 Breakdown Data by End User
5.1 Overview
5.2 Global Anti-inflammatory Therapeutics Breakdown Data by End User
6 North America
6.1 North America Anti-inflammatory Therapeutics by Countries
6.1.1 North America Anti-inflammatory Therapeutics Sales by Countries
6.1.2 North America Anti-inflammatory Therapeutics Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Anti-inflammatory Therapeutics by Product
6.3 North America Anti-inflammatory Therapeutics by End User
7 Europe
7.1 Europe Anti-inflammatory Therapeutics by Countries
7.1.1 Europe Anti-inflammatory Therapeutics Sales by Countries
7.1.2 Europe Anti-inflammatory Therapeutics Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Anti-inflammatory Therapeutics by Product
7.3 Europe Anti-inflammatory Therapeutics by End User
8 Asia Pacific
8.1 Asia Pacific Anti-inflammatory Therapeutics by Countries
8.1.1 Asia Pacific Anti-inflammatory Therapeutics Sales by Countries
8.1.2 Asia Pacific Anti-inflammatory Therapeutics Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Anti-inflammatory Therapeutics by Product
8.3 Asia Pacific Anti-inflammatory Therapeutics by End User
9 Central & South America
9.1 Central & South America Anti-inflammatory Therapeutics by Countries
9.1.1 Central & South America Anti-inflammatory Therapeutics Sales by Countries
9.1.2 Central & South America Anti-inflammatory Therapeutics Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Anti-inflammatory Therapeutics by Product
9.3 Central & South America Anti-inflammatory Therapeutics by End User
10 Middle East and Africa
10.1 Middle East and Africa Anti-inflammatory Therapeutics by Countries
10.1.1 Middle East and Africa Anti-inflammatory Therapeutics Sales by Countries
10.1.2 Middle East and Africa Anti-inflammatory Therapeutics Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Anti-inflammatory Therapeutics by Product
10.3 Middle East and Africa Anti-inflammatory Therapeutics by End User
11 Company Profiles
11.1 AbbVie
11.1.1 AbbVie Company Details
11.1.2 Company Business Overview
11.1.3 AbbVie Anti-inflammatory Therapeutics Sales, Revenue and Gross Margin (2014-2019)
11.1.4 AbbVie Anti-inflammatory Therapeutics Products Offered
11.1.5 AbbVie Recent Development
11.2 Amgen
11.2.1 Amgen Company Details
11.2.2 Company Business Overview
11.2.3 Amgen Anti-inflammatory Therapeutics Sales, Revenue and Gross Margin (2014-2019)
11.2.4 Amgen Anti-inflammatory Therapeutics Products Offered
11.2.5 Amgen Recent Development
11.3 Johnson & Johnson
11.3.1 Johnson & Johnson Company Details
11.3.2 Company Business Overview
11.3.3 Johnson & Johnson Anti-inflammatory Therapeutics Sales, Revenue and Gross Margin (2014-2019)
11.3.4 Johnson & Johnson Anti-inflammatory Therapeutics Products Offered
11.3.5 Johnson & Johnson Recent Development
11.4 Pfizer
11.4.1 Pfizer Company Details
11.4.2 Company Business Overview
11.4.3 Pfizer Anti-inflammatory Therapeutics Sales, Revenue and Gross Margin (2014-2019)
11.4.4 Pfizer Anti-inflammatory Therapeutics Products Offered
11.4.5 Pfizer Recent Development
11.5 Boehringer Ingelheim
11.5.1 Boehringer Ingelheim Company Details
11.5.2 Company Business Overview
11.5.3 Boehringer Ingelheim Anti-inflammatory Therapeutics Sales, Revenue and Gross Margin (2014-2019)
11.5.4 Boehringer Ingelheim Anti-inflammatory Therapeutics Products Offered
11.5.5 Boehringer Ingelheim Recent Development
11.6 Eli Lilly
11.6.1 Eli Lilly Company Details
11.6.2 Company Business Overview
11.6.3 Eli Lilly Anti-inflammatory Therapeutics Sales, Revenue and Gross Margin (2014-2019)
11.6.4 Eli Lilly Anti-inflammatory Therapeutics Products Offered
11.6.5 Eli Lilly Recent Development
11.7 Novartis
11.7.1 Novartis Company Details
11.7.2 Company Business Overview
11.7.3 Novartis Anti-inflammatory Therapeutics Sales, Revenue and Gross Margin (2014-2019)
11.7.4 Novartis Anti-inflammatory Therapeutics Products Offered
11.7.5 Novartis Recent Development
12 Future Forecast
12.1 Anti-inflammatory Therapeutics Market Forecast by Regions
12.1.1 Global Anti-inflammatory Therapeutics Sales Forecast by Regions 2019-2025
12.1.2 Global Anti-inflammatory Therapeutics Revenue Forecast by Regions 2019-2025
12.2 Anti-inflammatory Therapeutics Market Forecast by Product
12.2.1 Global Anti-inflammatory Therapeutics Sales Forecast by Product 2019-2025
12.2.2 Global Anti-inflammatory Therapeutics Revenue Forecast by Product 2019-2025
12.3 Anti-inflammatory Therapeutics Market Forecast by End User
12.4 North America Anti-inflammatory Therapeutics Forecast
12.5 Europe Anti-inflammatory Therapeutics Forecast
12.6 Asia Pacific Anti-inflammatory Therapeutics Forecast
12.7 Central & South America Anti-inflammatory Therapeutics Forecast
12.8 Middle East and Africa Anti-inflammatory Therapeutics Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Anti-inflammatory Therapeutics Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Figure Anti-inflammatory Therapeutics Product Picture
Table Anti-inflammatory Therapeutics Market Segments
Table Key Manufacturers Anti-inflammatory Therapeutics Covered
Table Global Anti-inflammatory Therapeutics Market Size Growth Rate by Product 2019-2025 (K Units) & (Million US$)
Figure Global Anti-inflammatory Therapeutics Sales Market Share by Product 2014-2025
Figure Anti-Inflammatory Biologicals Product Picture
Table Major Manufacturers of Anti-Inflammatory Biologicals
Figure NSAIDs Product Picture
Table Major Manufacturers of NSAIDs
Figure Corticosteroids Product Picture
Table Major Manufacturers of Corticosteroids
Table Global Anti-inflammatory Therapeutics Market Size Growth Rate by End User 2019-2025 (K Units)
Figure Hospitals
Figure Clinics
Figure Anti-inflammatory Therapeutics Report Years Considered
Figure Global Anti-inflammatory Therapeutics Market Size 2014-2025 (Million US$)
Figure Global Anti-inflammatory Therapeutics Sales 2014-2025 (K Units)
Table Global Anti-inflammatory Therapeutics Market Size by Regions 2014-2019 (K Units) & (Million US$)
Table Global Anti-inflammatory Therapeutics Sales by Regions 2014-2019 (K Units)
Table Global Anti-inflammatory Therapeutics Sales Market Share by Regions 2014-2019
Figure Global Anti-inflammatory Therapeutics Sales Market Share by Regions 2014-2019
Figure 2018 Global Anti-inflammatory Therapeutics Sales Market Share by Regions
Table Global Anti-inflammatory Therapeutics Revenue by Regions 2014-2019 (Million US$)
Table Global Anti-inflammatory Therapeutics Revenue Market Share by Regions 2014-2019
Figure Global Anti-inflammatory Therapeutics Revenue Market Share by Regions 2014-2019
Figure 2018 Global Anti-inflammatory Therapeutics Revenue Market Share by Regions
Table Global Anti-inflammatory Therapeutics Sales by Manufacturers (2014-2019) (K Units)
Table Global Anti-inflammatory Therapeutics Sales Share by Manufacturers (2014-2019)
Figure Global Anti-inflammatory Therapeutics Sales Share by Manufacturers in 2018
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Anti-inflammatory Therapeutics Revenue by Manufacturers (2014-2019) (Million USD)
Table Anti-inflammatory Therapeutics Revenue Share by Manufacturers (2014-2019)
Figure Anti-inflammatory Therapeutics Value Share by Manufacturers in 2018
Table Key Manufacturers Anti-inflammatory Therapeutics Price (2014-2019) (USD/Unit)
Table Anti-inflammatory Therapeutics Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Anti-inflammatory Therapeutics Product Type
Table Date of International Manufacturers Enter into Anti-inflammatory Therapeutics Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Anti-inflammatory Therapeutics Sales by Product (2014-2019) (K Units)
Table Global Anti-inflammatory Therapeutics Sales Share by Product (2014-2019)
Figure Global Anti-inflammatory Therapeutics Sales Market Share by Product (2014-2019)
Figure Global Anti-inflammatory Therapeutics Sales Market Share by Product in 2018
Table Global Anti-inflammatory Therapeutics Revenue by Product (2014-2019) (Million US$)
Table Global Anti-inflammatory Therapeutics Revenue Share by Product (2014-2019)
Figure Global Anti-inflammatory Therapeutics Revenue Market Share by Product (2014-2019)
Figure Global Anti-inflammatory Therapeutics Revenue Market Share by Product in 2018
Table Anti-inflammatory Therapeutics Price by Product 2014-2019 (USD/Unit)
Table Global Anti-inflammatory Therapeutics Sales by End User (2014-2019) (K Units)
Table Global Anti-inflammatory Therapeutics Sales Share by End User (2014-2019)
Figure Global Sales Anti-inflammatory Therapeutics Market Share by End User (2014-2019)
Figure Global Sales Anti-inflammatory Therapeutics Market Share by End User in 2018
Figure North America Anti-inflammatory Therapeutics Sales Growth Rate 2014-2019 (K Units)
Figure North America Anti-inflammatory Therapeutics Revenue Growth Rate 2014-2019 (Million US$)
Table North America Anti-inflammatory Therapeutics Sales by Countries (2014-2019) (K Units)
Table North America Anti-inflammatory Therapeutics Sales Market Share by Countries (2014-2019)
Figure 2018 North America Anti-inflammatory Therapeutics Sales Market Share by Countries
Table North America Anti-inflammatory Therapeutics Revenue by Countries (2014-2019) (Million US$)
Table North America Anti-inflammatory Therapeutics Revenue Market Share by Countries (2014-2019)
Figure 2018 North America Anti-inflammatory Therapeutics Revenue Market Share by Countries
Figure United States Anti-inflammatory Therapeutics Sales Growth Rate (2014-2019) (K Units)
Figure United States Anti-inflammatory Therapeutics Revenue Growth Rate (2014-2019) (K Units)
Figure Canada Anti-inflammatory Therapeutics Sales Growth Rate (2014-2019) (K Units)
Figure Canada Anti-inflammatory Therapeutics Revenue Growth Rate (2014-2019) (Million US$)
Figure Mexico Anti-inflammatory Therapeutics Sales Growth Rate (2014-2019) (K Units)
Figure Mexico Anti-inflammatory Therapeutics Revenue Growth Rate (2014-2019) (Million US$)
Table North America Anti-inflammatory Therapeutics Sales by Product (2014-2019) (K Units)
Table North America Anti-inflammatory Therapeutics Sales Market Share by Product (2014-2019)
Figure 2018 North America Anti-inflammatory Therapeutics Market Share by Product
Table North America Anti-inflammatory Therapeutics Sales by End User (2014-2019) (K Units)
Table North America Anti-inflammatory Therapeutics Sales Market Share by End User (2014-2019)
Figure 2018 North America Anti-inflammatory Therapeutics Market Share by End User
Figure Europe Anti-inflammatory Therapeutics Sales Growth Rate 2014-2019 (K Units)
Figure Europe Anti-inflammatory Therapeutics Revenue Growth Rate 2014-2019 (Million US$)
Table Europe Anti-inflammatory Therapeutics Sales by Countries (2014-2019) (K Units)
Table Europe Anti-inflammatory Therapeutics Sales Market Share by Countries (2014-2019)
Figure 2018 Europe Anti-inflammatory Therapeutics Sales Market Share by Countries
Table Europe Anti-inflammatory Therapeutics Revenue by Countries (2014-2019) (Million US$)
Table Europe Anti-inflammatory Therapeutics Revenue Market Share by Countries (2014-2019)
Figure 2018 Europe Anti-inflammatory Therapeutics Revenue Market Share by Countries
Figure Germany Anti-inflammatory Therapeutics Sales Growth Rate (2014-2019) (K Units)
Figure Germany Anti-inflammatory Therapeutics Revenue Growth Rate (2014-2019) (Million US$)
Figure France Anti-inflammatory Therapeutics Sales Growth Rate (2014-2019) (K Units)
Figure France Anti-inflammatory Therapeutics Revenue Growth Rate (2014-2019) (Million US$)
Figure UK Anti-inflammatory Therapeutics Sales Growth Rate (2014-2019) (K Units)
Figure UK Anti-inflammatory Therapeutics Revenue Growth Rate (2014-2019) (Million US$)
Figure Italy Anti-inflammatory Therapeutics Sales Growth Rate (2014-2019) (K Units)
Figure Italy Anti-inflammatory Therapeutics Revenue Growth Rate (2014-2019) (Million US$)
Figure Russia Anti-inflammatory Therapeutics Sales Growth Rate (2014-2019) (K Units)
Figure Russia Anti-inflammatory Therapeutics Revenue Growth Rate (2014-2019) (Million US$)
Table Europe Anti-inflammatory Therapeutics Sales by Product (2014-2019) (K Units)
Table Europe Anti-inflammatory Therapeutics Sales Market Share by Product (2014-2019)
Figure 2018 Europe Anti-inflammatory Therapeutics Market Share by Product
Table Europe Anti-inflammatory Therapeutics Sales by End User (2014-2019) (K Units)
Table Europe Anti-inflammatory Therapeutics Sales Market Share by End User (2014-2019)
Figure 2018 Europe Anti-inflammatory Therapeutics Market Share by End User
Figure Asia Pacific Anti-inflammatory Therapeutics Sales Growth Rate 2014-2019 (K Units)
Figure Asia Pacific Anti-inflammatory Therapeutics Revenue Growth Rate 2014-2019 (Million US$)
Table Asia Pacific Anti-inflammatory Therapeutics Sales by Countries (2014-2019) (K Units)
Table Asia Pacific Anti-inflammatory Therapeutics Sales Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Anti-inflammatory Therapeutics Sales Market Share by Countries
Table Asia Pacific Anti-inflammatory Therapeutics Revenue by Countries (2014-2019) (Million US$)
Table Asia Pacific Anti-inflammatory Therapeutics Revenue Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Anti-inflammatory Therapeutics Revenue Market Share by Countries
Figure China Anti-inflammatory Therapeutics Sales Growth Rate (2014-2019) (K Units)
Figure China Anti-inflammatory Therapeutics Revenue Growth Rate (2014-2019) (Million US$)
Figure Japan Anti-inflammatory Therapeutics Sales Growth Rate (2014-2019) (K Units)
Figure Japan Anti-inflammatory Therapeutics Revenue Growth Rate (2014-2019) (Million US$)
Figure Korea Anti-inflammatory Therapeutics Sales Growth Rate (2014-2019) (K Units)
Figure Korea Anti-inflammatory Therapeutics Revenue Growth Rate (2014-2019) (Million US$)
Figure India Anti-inflammatory Therapeutics Sales Growth Rate (2014-2019) (K Units)
Figure India Anti-inflammatory Therapeutics Revenue Growth Rate (2014-2019) (Million US$)
Figure Australia Anti-inflammatory Therapeutics Sales Growth Rate (2014-2019) (K Units)
Figure Australia Anti-inflammatory Therapeutics Revenue Growth Rate (2014-2019) (Million US$)
Figure Indonesia Anti-inflammatory Therapeutics Sales Growth Rate (2014-2019) (K Units)
Figure Indonesia Anti-inflammatory Therapeutics Revenue Growth Rate (2014-2019) (Million US$)
Figure Malaysia Anti-inflammatory Therapeutics Sales Growth Rate (2014-2019) (K Units)
Figure Malaysia Anti-inflammatory Therapeutics Revenue Growth Rate (2014-2019) (Million US$)
Figure Philippines Anti-inflammatory Therapeutics Sales Growth Rate (2014-2019) (K Units)
Figure Philippines Anti-inflammatory Therapeutics Revenue Growth Rate (2014-2019) (Million US$)
Figure Thailand Anti-inflammatory Therapeutics Sales Growth Rate (2014-2019) (K Units)
Figure Thailand Anti-inflammatory Therapeutics Revenue Growth Rate (2014-2019) (Million US$)
Figure Vietnam Anti-inflammatory Therapeutics Sales Growth Rate (2014-2019) (K Units)
Figure Vietnam Anti-inflammatory Therapeutics Revenue Growth Rate (2014-2019) (Million US$)
Figure Singapore Anti-inflammatory Therapeutics Sales Growth Rate (2014-2019) (K Units)
Figure Singapore Anti-inflammatory Therapeutics Revenue Growth Rate (2014-2019) (Million US$)
Table Asia Pacific Anti-inflammatory Therapeutics Sales by Product (2014-2019) (K Units)
Table Asia Pacific Anti-inflammatory Therapeutics Sales Market Share by Product (2014-2019)
Figure 2018 Asia Pacific Anti-inflammatory Therapeutics Market Share by Product
Table Asia Pacific Anti-inflammatory Therapeutics Sales by End User (2014-2019) (K Units)
Table Asia Pacific Anti-inflammatory Therapeutics Sales Market Share by End User (2014-2019)
Figure 2018 Asia Pacific Anti-inflammatory Therapeutics Market Share by End User
Figure Central & South America Anti-inflammatory Therapeutics Sales Growth Rate 2014-2019 (K Units)
Figure Central & South America Anti-inflammatory Therapeutics Revenue Growth Rate 2014-2019 (Million US$)
Table Central & South America Anti-inflammatory Therapeutics Sales by Countries (2014-2019) (K Units)
Table Central & South America Anti-inflammatory Therapeutics Sales Market Share by Countries (2014-2019)
Figure 2018 Central & South America Anti-inflammatory Therapeutics Sales Market Share by Countries
Table Central & South America Anti-inflammatory Therapeutics Revenue by Countries (2014-2019) (Million US$)
Table Central & South America Anti-inflammatory Therapeutics Revenue Market Share by Countries (2014-2019)
Figure 2018 Central & South America Anti-inflammatory Therapeutics Revenue Market Share by Countries
Figure Brazil Anti-inflammatory Therapeutics Sales Growth Rate (2014-2019) (K Units)
Figure Brazil Anti-inflammatory Therapeutics Revenue Growth Rate (2014-2019) (Million US$)
Figure Argentina Anti-inflammatory Therapeutics Sales Growth Rate (2014-2019) (K Units)
Figure Argentina Anti-inflammatory Therapeutics Revenue Growth Rate (2014-2019) (Million US$)
Table Central & South America Anti-inflammatory Therapeutics Sales by Product (2014-2019) (K Units)
Table Central & South America Anti-inflammatory Therapeutics Sales Market Share by Product (2014-2019)
Figure 2018 Central & South America Anti-inflammatory Therapeutics Market Share by Product
Table Central & South America Anti-inflammatory Therapeutics Sales by End User (2014-2019) (K Units)
Table Central & South America Anti-inflammatory Therapeutics Sales Market Share by End User (2014-2019)
Figure 2018 Central & South America Anti-inflammatory Therapeutics Market Share by End User
Figure Middle East and Africa Anti-inflammatory Therapeutics Sales Growth Rate 2014-2019 (K Units)
Figure Middle East and Africa Anti-inflammatory Therapeutics Revenue Growth Rate 2014-2019 (Million US$)
Table Middle East and Africa Anti-inflammatory Therapeutics Sales by Countries (2014-2019) (K Units)
Table Middle East and Africa Anti-inflammatory Therapeutics Sales Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Anti-inflammatory Therapeutics Sales Market Share by Countries
Table Middle East and Africa Anti-inflammatory Therapeutics Revenue by Countries (2014-2019) (Million US$)
Table Middle East and Africa Anti-inflammatory Therapeutics Revenue Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Anti-inflammatory Therapeutics Revenue Market Share by Countries
Figure GCC Countries Anti-inflammatory Therapeutics Sales Growth Rate (2014-2019) (K Units)
Figure GCC Countries Anti-inflammatory Therapeutics Revenue Growth Rate (2014-2019) (Million US$)
Figure Turkey Anti-inflammatory Therapeutics Sales Growth Rate (2014-2019) (K Units)
Figure Turkey Anti-inflammatory Therapeutics Revenue Growth Rate (2014-2019) (Million US$)
Figure Egypt Anti-inflammatory Therapeutics Sales Growth Rate (2014-2019) (K Units)
Figure Egypt Anti-inflammatory Therapeutics Revenue Growth Rate (2014-2019) (Million US$)
Figure South Africa Anti-inflammatory Therapeutics Sales Growth Rate (2014-2019) (K Units)
Figure South Africa Anti-inflammatory Therapeutics Revenue Growth Rate (2014-2019) (Million US$)
Table Middle East and Africa Anti-inflammatory Therapeutics Sales by Product (2014-2019) (K Units)
Table Middle East and Africa Anti-inflammatory Therapeutics Sales Market Share by Product (2014-2019)
Figure 2018 Middle East and Africa Anti-inflammatory Therapeutics Market Share by Product
Table Middle East and Africa Anti-inflammatory Therapeutics Sales by End User (2014-2019) (K Units)
Table Middle East and Africa Anti-inflammatory Therapeutics Sales Market Share by End User (2014-2019)
Figure 2018 Middle East and Africa Anti-inflammatory Therapeutics Market Share by End User
Table AbbVie Company Details
Table AbbVie Anti-inflammatory Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table AbbVie Recent Development
Table Amgen Company Details
Table Amgen Anti-inflammatory Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Amgen Recent Development
Table Johnson & Johnson Company Details
Table Johnson & Johnson Anti-inflammatory Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Johnson & Johnson Recent Development
Table Pfizer Company Details
Table Pfizer Anti-inflammatory Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Pfizer Recent Development
Table Boehringer Ingelheim Company Details
Table Boehringer Ingelheim Anti-inflammatory Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Boehringer Ingelheim Recent Development
Table Eli Lilly Company Details
Table Eli Lilly Anti-inflammatory Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Eli Lilly Recent Development
Table Novartis Company Details
Table Novartis Anti-inflammatory Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Novartis Recent Development
Table Global Anti-inflammatory Therapeutics Sales Forecast by Regions 2019-2025 (K Units)
Table Global Anti-inflammatory Therapeutics Sales Market Share Forecast by Regions 2019-2025
Table Global Anti-inflammatory Therapeutics Revenue Forecast by Regions 2019-2025 (Million US$)
Table Global Anti-inflammatory Therapeutics Revenue Market Share Forecast by Regions 2019-2025
Table Global Anti-inflammatory Therapeutics Sales Forecast by Product 2019-2025 (K Units)
Table Global Anti-inflammatory Therapeutics Sales Market Share Forecast by Product 2019-2025
Table Global Anti-inflammatory Therapeutics Revenue Forecast by Product 2019-2025 (Million US$)
Table Global Anti-inflammatory Therapeutics Revenue Market Share Forecast by Product 2019-2025
Table Global Anti-inflammatory Therapeutics Sales Forecast by End User 2019-2025 (K Units)
Table Global Anti-inflammatory Therapeutics Sales Market Share Forecast by End User 2019-2025
Figure North America Anti-inflammatory Therapeutics Sales Growth Rate Forecast (2019-2025) (K Units)
Figure North America Anti-inflammatory Therapeutics Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Europe Anti-inflammatory Therapeutics Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Europe Anti-inflammatory Therapeutics Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Asia Pacific Anti-inflammatory Therapeutics Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Asia Pacific Anti-inflammatory Therapeutics Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Central & South America Anti-inflammatory Therapeutics Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Central & South America Anti-inflammatory Therapeutics Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Middle East and Africa Anti-inflammatory Therapeutics Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Middle East and Africa Anti-inflammatory Therapeutics Revenue Growth Rate Forecast (2019-2025) (Million US$)
Table Anti-inflammatory Therapeutics Value Chain
Table Anti-inflammatory Therapeutics Customers List
Table Anti-inflammatory Therapeutics Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
免疫介在性炎症性疾患治療の世界市場：市場規模・現状・予測 Immune-Mediated Inflammatory Diseases Treatment is any of a group of conditions or diseases that lack a definitive etiology, but which are characterized by common inflammatory pathways leading to inflammation, and which may result from, or be triggered by, a dysregulation of the normal immune respon…- 炎症性腸疾患の世界市場：市場規模・現状・予測 Inflammatory bowel disease (IBD) is a group of inflammatory conditions of the colon and small intestine. Crohn's diseaseand ulcerative colitis are the principal types of inflammatory bowel disease. Crohn's disease affects the small intestine and large intestine, as well as the mouth, esophagus, stom…
- 炎症性腸疾患薬の世界市場：インサイト・予測 Inflammatory bowel disease is a condition generally caused when immune system attacks harmless bacteria, virus, or food in the intestine. The most common inflammatory bowel diseases are ulcerative colitis and Crohns disease. The growth in prevalence of inflammatory bowel diseases such as ulcerative …
- 抗肥満処方薬の世界市場：インサイト・予測 Growing demand for obesity is one of the recent trends in the global Anti-Obesity Prescription Drugs market. Moreover, this trend is further anticipated to drive the global Anti-Obesity Prescription Drugs market over the forecast period. Furthermore, growing obesity due unhealthy food and lifestyle …
- 犬インフルエンザ治療薬の世界市場：市場規模・現状・予測 Canine flu, which is also called dog flu; is a contagious disease that affects the dog’s respiratory system. It is mainly caused by canine influenza virus/Type An influenza virus. There are two types of influenza viruses H3N2 virus H3N8 virus. In 2018, the global Canine Flu Therapeutics market size …